"strongly".... a bit of justifiable hype.... but when considering we originally had a target of 10 out of 54, and now have 22 out of 57.... I would say the results merit being labelled "strongly".
The perplexing issue is not knowing when a Pharma will make a move...if at all.
The results are in line with what long term shareholders have been expecting, but the market is a harsh task master in current times.
Not to say an interested party isn't ready to pounce right now... I must not blink!!
- Forums
- ASX - By Stock
- Ann: Updated positive data from Phase 2 Melanoma trial of CAVATAK
"strongly".... a bit of justifiable hype.... but when...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)